Bobby Gaspar
2019
In 2019, Bobby Gaspar earned a total compensation of $920.7K as Chief Executive Officer at Orchard Therapeutics plc.
Compensation breakdown
| Non-Equity Incentive Plan | $175,125 |
|---|---|
| Option Awards | $401,260 |
| Salary | $344,348 |
| Total | $920,733 |
Gaspar received $401.3K in option awards, accounting for 44% of the total pay in 2019.
Gaspar also received $175.1K in non-equity incentive plan and $344.3K in salary.
Rankings
In 2019, Bobby Gaspar's compensation ranked 9,657th out of 13,971 executives tracked by ExecPay. In other words, Gaspar earned more than 30.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,657 out of 13,971 | 31st |
Division Manufacturing | 3,888 out of 5,701 | 32nd |
Major group Chemicals And Allied Products | 1,479 out of 2,200 | 33rd |
Industry group Drugs | 1,264 out of 1,886 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 282 out of 389 | 28th |
Source: SEC filing on April 28, 2021.
Gaspar's colleagues
We found two more compensation records of executives who worked with Bobby Gaspar at Orchard Therapeutics plc in 2019.